zolgensmareimbursement.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Home Page - ZOLGENSMA® (onasemnogene
Description Reimbursement ZOLGENSMA™ (onasemnogene abeparvovec-axgt). Important Safety Information.Full Prescribing Information. Indicated for the treatment of pediatric patients with spinalmuscular atrophy (SMA) Type 1. Treatment Center Locator. Patient
Keywords N/A
Server Information
WebSite zolgensmareimbursement faviconzolgensmareimbursement.com
Host IP 104.196.239.80
Location United States
Related Websites
Site Rank
More to Explore
zolgensmareimbursement.com Valuation
US$1,864,482
Last updated: 2023-05-18 22:13:25

zolgensmareimbursement.com has Semrush global rank of 5,676,808. zolgensmareimbursement.com has an estimated worth of US$ 1,864,482, based on its estimated Ads revenue. zolgensmareimbursement.com receives approximately 215,133 unique visitors each day. Its web server is located in United States, with IP address 104.196.239.80. According to SiteAdvisor, zolgensmareimbursement.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,864,482
Daily Ads Revenue US$1,722
Monthly Ads Revenue US$51,632
Yearly Ads Revenue US$619,582
Daily Unique Visitors 14,343
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
zolgensmareimbursement.com. 86398 IN A IP: 104.196.239.80
zolgensmareimbursement.com. 1800 IN NS NS Record: a7-64.akam.net.
zolgensmareimbursement.com. 1800 IN NS NS Record: dns4.novartis.com.
zolgensmareimbursement.com. 1800 IN NS NS Record: dns2.novartis.com.
zolgensmareimbursement.com. 1800 IN NS NS Record: dns1.novartis.com.
zolgensmareimbursement.com. 1800 IN NS NS Record: a1-254.akam.net.
zolgensmareimbursement.com. 1800 IN NS NS Record: dns3.novartis.com.
zolgensmareimbursement.com. 1800 IN NS NS Record: a9-65.akam.net.
zolgensmareimbursement.com. 1800 IN NS NS Record: a28-67.akam.net.
zolgensmareimbursement.com. 1800 IN NS NS Record: a2-66.akam.net.
zolgensmareimbursement.com. 1800 IN NS NS Record: a24-65.akam.net.
HtmlToTextCheckTime:2023-05-18 22:13:25
Important Safety Information Full Prescribing Information For Patients and Caregivers › Home Home Page Select Page Reimbursement Resources ZOLGENSMA® (onasemnogene abeparvovec-xioi) is the first one-time-only gene therapy for pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) Your resource for understanding reimbursement for ZOLGENSMA The materials below are provided to offer reimbursement support to your office throughout the ZOLGENSMA treatment pathway: Best Practice Tool Best Practice Tool An interactive PDF detailing best practices along the pathway to approval for insurance coverage of ZOLGENSMA Best Practice Tool Health Plan Policy Materials Prior Authorization Criteria Guide A simple guide to anticipated prior authorization criteria for ZOLGENSMA Prior Authorization Criteria Guide Letter of Medical Necessity Guide Suggestions for key elements to include when writing a letter of medical necessity in support of ZOLGENSMA Letter of Medical Necessity
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 29 Jul 2022 08:56:36 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: http://www.zolgensmareimbursement.com/

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 29 Jul 2022 08:56:37 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://www.zolgensmareimbursement.com/

HTTP/2 200 
server: nginx
date: Fri, 29 Jul 2022 08:56:38 GMT
content-type: text/html; charset=UTF-8
content-length: 58414
vary: Accept-Encoding
vary: Accept-Encoding
set-cookie: my_cookie=some%20default%20value; expires=Sat, 30-Jul-2022 08:51:00 GMT; Max-Age=86400
x-pingback: https://www.zolgensmareimbursement.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
accept-ranges: bytes
zolgensmareimbursement.com Whois Information
Domain Name: ZOLGENSMAREIMBURSEMENT.COM
Registry Domain ID: 2502258832_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2021-03-31T14:16:25Z
Creation Date: 2020-03-11T13:16:43Z
Registry Expiry Date: 2024-03-11T13:16:43Z
Registrar: MarkMonitor Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2086851750
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: A1-254.AKAM.NET
Name Server: A2-66.AKAM.NET
Name Server: A24-65.AKAM.NET
Name Server: A28-67.AKAM.NET
Name Server: A7-64.AKAM.NET
Name Server: A9-65.AKAM.NET
Name Server: DNS1.NOVARTIS.COM
Name Server: DNS2.NOVARTIS.COM
Name Server: DNS3.NOVARTIS.COM
Name Server: DNS4.NOVARTIS.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-29T09:03:03Z <<<